Blood Screening Market 2025 Trends, Business Opportunities, Future Demand and Forecast 2033

The global blood screening market was valued at USD 2.99 billion in 2023 and is anticipated to grow at a CAGR of 11.6% from 2024 to 2033.

2. Market Dynamics

Drivers:

• Increasing Demand for Safe Blood Transfusions: Growing volume of blood transfusions worldwide due to surgeries, trauma care, and chronic diseases.
• Rising Prevalence of Blood-Borne Infections: HIV, Hepatitis B & C, and other infectious diseases increase the need for stringent screening.
• Technological Advancements: Introduction of rapid, automated, and highly sensitive screening methods.
• Government Regulations and Policies: Strict guidelines and mandatory screening protocols boost market demand.

Restraints:

• High Cost of Advanced Screening Technologies: Cost-prohibitive equipment limits accessibility in developing countries.
• Lack of Infrastructure in Low-Resource Settings: Insufficient blood screening facilities in rural and underserved areas.
• False Positives/Negatives: Accuracy concerns affect reliability and trust in screening processes.

Opportunities:

• Emerging Markets Expansion: Rising healthcare expenditure and blood donation awareness in Asia-Pacific and Latin America.
• Point-of-Care Testing (POCT): Growing adoption of portable blood screening devices.
• Integration with Digital Health: AI and machine learning enhancing screening efficiency and data management.

3. Segment Analysis

By Technology:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR)
• Western Blot
• Immunofluorescence Assay
• Other Technologies

By Application:

• Blood Banks
• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes

By Screening Type:

• Infectious Disease Screening
• Genetic Screening
• Blood Typing and Compatibility Testing

By End User:

• Public Blood Banks
• Private Blood Banks

By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

4. Some of the Key Market Players

• Abbott Laboratories
• Roche Diagnostics
• bioMérieux SA
• Grifols, S.A.
• Danaher Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc.
• Ortho Clinical Diagnostics
• F. Hoffmann-La Roche Ltd.
• Wadsworth Center

5. Report Description

This report presents a comprehensive analysis of the Global Blood Screening Market, detailing key market trends, growth drivers, challenges, and future opportunities. It provides segmentation by technology, application, screening type, and geography. The report covers technological innovations, regulatory frameworks, and competitive strategies adopted by leading players. Forecasts through 2030 offer insights for stakeholders to capitalize on emerging market dynamics.

Request Sample PDF @ https://www.thebrainyinsights.com/enquiry/sample-request/14155

6. Table of Contents

1. Executive Summary
2. Market Introduction
3. Research Methodology
4. Market Dynamics
5. 4.1 Drivers
6. 4.2 Restraints
7. 4.3 Opportunities
8. Technological Innovations and Trends
9. Segment Analysis
10. 6.1 By Technology
11. 6.2 By Application
12. 6.3 By Screening Type
13. 6.4 By End User
14. 6.5 By Region
15. Regulatory Landscape
16. Competitive Landscape
17. 8.1 Company Profiles
18. 8.2 Market Share Analysis
19. 8.3 Recent Developments
20. Strategic Recommendations and Forecast (2025–2030)
21. Appendix